Related Experiment Videos
[Action of thomicide on bacterial cells. The membranotropic activity of thomicide]
Abstract:
It was shown that a combined drug thomicide impaired permeability of cell membranes in Micrococcus luteus 2665 and Staphylococcus aureus 209P inducing production of substances with the absorption maxima at 260 nm. Active lysis of the M. luteus 2665 protoplasts under the action of thomicide used in a dose of at least 60 micrograms per 1 mg of the protoplast proteins was observed. Thomicide inhibited oxidation of the substrates by intact cells of the staphylococci and micrococci. Respiration of the micrococcal protoplasts was inhibited by thomicide in concentrations inducing lysis of the protoplasts. Impairment of function and the state of the membranes of the bacterial cells (production of compounds with the absorption maxima at 260 nm, protoplast lysis and respiration inhibition) was recorded at thomicide concentrations lower than the bactericidal ones. The membranotropic activity of thomicide was associated with thermostable component of the complex.
Insights
The drug thomicide damages bacterial cell membranes in Micrococcus luteus and Staphylococcus aureus, affecting cell functions even at sub-lethal doses. This membranotropic activity stems from a heat-stable component within the drug complex.
Area of Science:
- Microbiology
- Biochemistry
- Cell Biology
Context:
- Bacterial cell membrane integrity is crucial for microbial survival and function.
- Understanding drug interactions with bacterial membranes is key to developing new antimicrobial agents.
- Thomicide is a combined drug with potential antimicrobial properties.
Purpose:
- To investigate the effects of thomicide on the cell membranes of Micrococcus luteus and Staphylococcus aureus.
- To determine the concentrations at which thomicide impairs bacterial membrane function and viability.
- To identify the component of thomicide responsible for its membranotropic activity.
Summary:
- Thomicide was found to impair cell membrane permeability in Micrococcus luteus and Staphylococcus aureus, leading to the release of substances with absorption maxima at 260 nm.
- Significant lysis of Micrococcus luteus protoplasts occurred at thomicide concentrations of 60 µg/mg.
- Thomicide inhibited substrate oxidation in intact bacterial cells and respiration in micrococcal protoplasts at concentrations below bactericidal levels.
- The observed membranotropic effects, including altered membrane permeability, protoplast lysis, and respiration inhibition, were linked to a thermostable component of thomicide.
Impact:
- Reveals thomicide's mechanism of action involves direct disruption of bacterial cell membranes.
- Suggests thomicide's potential as an antimicrobial agent targeting membrane integrity.
- Highlights the role of a thermostable component in thomicide's membranotropic activity, guiding future drug development.